“…The use of VPA in patients with intracranial bleedings is questionable because of the various effects of VPA on platelet number and function as well as on several clotting factors [247,248]. But, in general, the safety of i/v VPA, even at high doses, fast infusion rates and in cardiac instable patients, was demonstrated in several studies [249][250][251][252][253][254][255][256][257][258][259]. However, prospective randomised well-(i.e.…”